| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08:06 | UBS raises Kusuri no Aoki stock price target on medium-term plan | ||
| 07:54 | UBS reiterates Neutral rating on Nike stock amid brand strength signs | ||
| 07:54 | Indosat stock maintains Buy rating at UBS as company plans fiber asset transfer | ||
| 07:54 | Nvidia stock gains as Baird reiterates Outperform rating on AI deal | ||
| Do | Nomura downgrades Resona Holdings stock rating to Neutral despite price target hike | ||
| Do | JPMorgan downgrades Daiwa Securities Group stock rating to Neutral | ||
| Do | Nomura upgrades Hankyu Hanshin Holdings stock rating to Buy on undervaluation | ||
| Do | Caliway submits IND application for weight management drug study | ||
| Do | Cathie Wood's ARK buys WeRide stock, sells Ibotta | ||
| Mi | ExGen acquires second silver stream on South American gold mine | ||
| Mi | XTL Biopharmaceuticals receives Nasdaq minimum bid price notice | ||
| Mi | Sidus Space closes $25 million public offering of common stock | ||
| Mi | ImmuCell shifts focus to First Defense after FDA setback for Re-Tain | ||
| Mi | Biohaven's depression drug misses primary endpoint in Phase 2 study | ||
| Mi | Agios Pharma stock price target raised to $62 from $48 at H.C. Wainwright | ||
| Mi | Travere Therapeutics stock gains as FDA messaging on proteinuria endpoint boosts Filspari approval hopes | ||
| Mi | 30-year mortgage rate drops to 6.18%, offering holiday relief | ||
| Mi | U.S. regulator issues emergency permit for Sable's Santa Ynez pipeline | ||
| Mi | WORK Medical to implement 1-for-100 reverse stock split | ||
| Mi | Can-Fite BioPharma stock rating downgraded to Hold by D. Boral Capital | ||
| Mi | Comstock Mining stock rating downgraded to Market Perform by Noble Capital | ||
| Mi | Picard Medical secures $50 million private placement financing | ||
| Mi | Visa funds $500m litigation escrow, Baird reiterates Outperform rating | ||
| Mi | WhiteFiber stock price target lowered to $40 at B.Riley on revised EBITDA outlook | ||
| Mi | CompoSecure stock price target raised to $25 from $21 at Lake Street |